Koushyar, Sarah, Jiang, Wen Guo ORCID: https://orcid.org/0000-0002-3283-1111 and Dart, Dafydd Alwyn 2015. Unveiling the potential of prohibitin in cancer. Cancer Letters 369 (2) , pp. 316-322. 10.1016/j.canlet.2015.09.012 |
PDF
- Published Version
Available under License Creative Commons Attribution Non-commercial No Derivatives. Download (607kB) |
Abstract
Recently, research has shed new light on the role of Prohibitin (PHB) in cancer pathogenesis across an array of cancer types. Important mechanisms for PHB have been unveiled in several cancers, especially with regard to the androgen independent state of prostate cancer (PC) and oestrogen dependent breast cancer. However, PHB is often overlooked due to its complex but subtle roles within the cell. Having gathered both historical and current research exploring PHB's role in different cancer types including prostate and breast, here we aim to pair this information with its molecular properties in the hope of translating this information into a clinical perspective, thus discussing its possible use in future cancer therapy.
Item Type: | Article |
---|---|
Date Type: | Publication |
Status: | Published |
Schools: | Medicine |
Subjects: | R Medicine > RC Internal medicine > RC0254 Neoplasms. Tumors. Oncology (including Cancer) |
Uncontrolled Keywords: | Prohibitin; Prostate cancer; Breast cancer; Cell cycle; Cancer therapy |
Publisher: | Elsevier |
ISSN: | 0304-3835 |
Funders: | Cancer Research Wales |
Date of First Compliant Deposit: | 30 March 2016 |
Date of Acceptance: | 19 September 2015 |
Last Modified: | 11 Oct 2023 18:50 |
URI: | https://orca.cardiff.ac.uk/id/eprint/82004 |
Citation Data
Cited 38 times in Scopus. View in Scopus. Powered By Scopus® Data
Actions (repository staff only)
Edit Item |